|
Tetrachloroethylene exposure history of breast cancer subjects, adjusteda odds ratios, and 95% confidence intervals. |
||||
| Latency period, years |
Exposed Cases |
Exposed Controls |
Adjusted ORs (95 % CI) |
|
|
|
||||
| 0 |
Non-proxy Subjects |
101 |
88 |
1.1 (0.8–1.5) |
| All Subjects |
155 |
136 |
1.1 (0.8–1.4) |
|
| 5 |
Non-proxy Subjects |
87 |
69 |
1.2 (0.9–1.8) |
| All Subjects |
129 |
107 |
1.2 (0.9–1.6) |
|
| 7 |
Non-proxy Subjects |
71 |
61 |
1.1 (0.8–1.6) |
| All Subjects |
111 |
96 |
1.1 (0.8–1.5) |
|
| 9 |
Non-proxy Subjects |
63 |
57 |
1.1 (0.7–1.6) |
| All Subjects |
97 |
85 |
1.1 (0.8–1.5) |
|
| 11 |
Non-proxy Subjects |
49 |
43 |
1.1 (0.6–1.7) |
| All Subjects |
79 |
65 |
1.2 (0.8–1.7) |
|
| 13 |
Non-proxy Subjects |
43 |
32 |
1.3 (0.7–2.1) |
| All Subjects |
61 |
45 |
1.3 (0.9–2.0) |
|
| 15 |
Non-proxy Subjects |
30 |
21 |
1.4 (0.7–2.6) |
| All Subjects |
44 |
31 |
1.4 (0.9–2.3) |
|
| 17 |
Non-proxy Subjects |
15 |
15 |
1.0 (0.4–2.2) |
| All Subjects |
21 |
21 |
1.0 (0.6–2.0) |
|
| 19 |
Non-proxy Subjects |
6 |
6 |
1.1 (0.3–3.5) |
| All Subjects |
9 |
9 |
1.1 (0.4–2.9) |
|
|
a The OR was calculated relative to never-exposed cases (n = 360 for Non-Proxy, n = 517 for ALL) and controls (n = 336 for Non-Proxy, n = 480 for All). Controlled for age at diagnosis or index year, family history of breast cancer, personal history of breast cancer (before current diagnosis or index year), age at first live-birth or still birth, occupational exposure to PCE, and vital status at interview (for All analysis only). | ||||
Vieira et al. Environmental Health: A Global Access Science Source 2005 4:3 doi:10.1186/1476-069X-4-3 |
||||